You can now review and comment on this draft guideline.
The consultation closes at 5pm on Monday 31st January 2022
How to comment
1. Register your organisation or comment as an individual
If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.
Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.
We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.
2. Read the consultation documents
Documents to comment on:
- Draft guideline – just the recommendations
Evidence reviews
- Evidence review committee discussion
- Evidence review A - Information and support for patients (including people who may become pregnant), their families and carers
- Evidence review B - Coordination of care
- Evidence review C - Non-pharmacological management of fatigue
- Evidence review D - The pharmacological management of fatigue
- Evidence review E - Pharmacological management of mobility (updated 25 January 2022)
- Evidence review F - Pharmacological management of spasticity
- Evidence review G - Non-pharmacological management of pain
- Evidence review H - Non-pharmacological management of memory and cognition
- Evidence review I - Pharmacological management of ataxia and tremor
Supplementary Documents
- Supporting documentation A - Cost-utility analysis (updated 25 January 2022)
- Appendix - evidence review H1 - Non-pharmacological management of memory and cognitive problems
- Methods
- Economic model
- Acknowledgements
If you want to review the economic model, please see 5. Economic models below and fill in the confidentiality form.
Other information about the consultation
- Equality impact assessment 3
- Committee membership list
- Developing NICE guidelines: how to get involved
3. Add your comments
- You must use this comments form
- You must declare any links with, or funding from, the tobacco industry
If you share similar views with another organisation, send a joint response.
Make sure you consider:
- The areas that will have the biggest impact on practice and be challenging to implement
- How to help users overcome challenges
Developing NICE guidelines: how to get involved suggests some other areas to comment on.
4. Email the form to us
Email: MultipleSclerosisUpdate@nice.org.uk
Deadline: 5pm on Monday 31st January 2022
5. Economic model
The developer has produced an economic model to support the guideline on Multiple sclerosis in adults: management. To receive an executable version of this model, please submit a request to MultipleSclerosisUpdate@nice.org.uk with a signed copy of the confidentiality acknowledgement and undertaking form.
We will then send you a link to an executable version of the economic model by email. The deadline for returning your comments is the same as for the guideline consultation: 5pm on Monday 31st January 2022
This page was last updated: